Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Mallinckrodt
McKesson
Harvard Business School
McKinsey

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Litigation Details for AstraZeneca AB v. Wockhardt Bio AG (D. Del. 2014)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Small Molecule Drugs cited in AstraZeneca AB v. Wockhardt Bio AG
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for AstraZeneca AB v. Wockhardt Bio AG (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-05-23 1 05/23/14 Page 4 of 8 PageID #: 4 6,395,767 (“the ’767 patent”), which issued on May 28, 2002. A true…expiration of U.S. Patent Nos. RE44,186 (“the RE’186 patent”) and 7,951,400 (“the ’400 patent”) (together, … This is an action for patent infringement arising under the patent laws of the United States, … PATENTS-IN-SUIT 14. On April 30, 2013, the U.S. Patent and Trademark Office…Peptidase IV and Method.” The RE’186 patent is a reissue of U.S. Patent No. External link to document
2014-09-23 16 than April 15, 2014. Date of Expiration of Patent: 7,951,400 (November 30, 2028); RE 44,186 (July 31, 2023… Amended Supplemental information for patent cases involving an Abbreviated New Drug Application… 23 May 2014 1:14-cv-00667 830 Patent None District Court, D. Delaware External link to document
2014-05-23 4 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE44,186; 7,951,400;. (dmp, ) (Entered… 23 May 2014 1:14-cv-00667 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Merck
Johnson and Johnson
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.